Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Trop Med Int Health. 2020 Aug;25(8):962-975. doi: 10.1111/tmi.13442. Epub 2020 Jun 8.
To assess the quality of antibiotics sampled from authorised sales outlets (ATs) (i.e. hospitals/health centres, pharmacies and licensed chemical shops) and unauthorised sales outlets (UATs) (mainly street vendors) in Ghana and to explore the health-seeking behaviour of medicine consumers.
The contents of 14 active pharmaceutical ingredients (APIs) in 348 sampled products were determined using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Data on health-seeking practices were collected through entry and exit interviews and field observations from ATs and UATs.
It was observed that 66.38% of all sampled antibiotic products were substandard; they either contained less (<90%) or more API (>110%) than the label claim. Medicines from UATs recorded substantially less API contents than those from ATs (F = 43.01, P < 0.0001). For example, 90.54% of street vendor samples contained < 90% of the APIs. 75.93% of consumers often sought self-treatment with drugs without a prescription from UATs, as they perceived UATs as easily accessible, trustworthy and knowledgeable, and their medicines as inexpensive. These consumers rather thought of the formal healthcare providers as alternative sources.
Consumers who purchase from UATs are at high risk of receiving substandard medicines. The quality of medicines in the national healthcare system, in the supply chain and in the distribution system needs to be monitored regularly to reduce the incidence of substandard medicines and their impact on antimicrobial resistance. The fight against substandard medicines needs to incorporate a full understanding of socioeconomic factors that drive consumer decisions regarding their health and choice of healthcare providers.
评估加纳授权销售点(ATs)(即医院/卫生中心、药店和持牌化学店)和非授权销售点(UATs)(主要是街头小贩)采集的抗生素的质量,并探讨药品消费者的寻医行为。
使用经过验证的液相色谱-串联质谱(LC-MS/MS)方法测定 348 个采样产品中 14 种活性药物成分(APIs)的含量。通过对 ATs 和 UATs 的入口和出口访谈以及现场观察收集有关寻医行为的数据。
观察到,所有采样抗生素产品中,有 66.38%的产品不符合标准;它们要么含有少于(<90%)标签宣称的 API(>110%),要么含有更多的 API。来自 UATs 的药品所含 API 含量明显低于 ATs(F = 43.01,P < 0.0001)。例如,90.54%的街头小贩样本中含有<90%的 API。75.93%的消费者经常从 UATs 自行购买未经处方的药物进行治疗,因为他们认为 UATs 易于获得、值得信赖且知识渊博,而且他们的药品价格低廉。这些消费者更倾向于将正规医疗保健提供者视为替代来源。
从 UATs 购买药品的消费者面临着接受不合格药品的高风险。需要定期监测国家卫生保健系统、供应链和分销系统中的药品质量,以减少不合格药品的发生及其对抗菌素耐药性的影响。打击不合格药品需要充分了解驱动消费者对健康和医疗保健提供者做出决策的社会经济因素。